U.S. Government's interoperable identity management standards meet NHIN’s requirements

NewsGuard 100/100 Score

Achieving the secure nationwide exchange of health information and patient medical information using the Internet will be advanced by adopting existing standards, technology and currently used approaches to authenticate digital identities, according to testimony presented today to the National Health Information Network (NHIN) committee advising on the development of a nationwide health information infrastructure. The testimony was delivered by SAFE-BioPharma Association, the non-profit that developed and maintains the SAFE-BioPharma® digital identity and signature standard.

“The U.S. Government has a well-developed set of interoperable identity management standards that meet the NHIN’s privacy, security and confidentiality requirements. These standards are robust and provide the confidence needed to exchange sensitive health information electronically among trusted parties”

Vetting and authenticating digital identities and managing their access to different types of information are necessary to maintain patient confidentiality and other legal and regulatory requirements.

“The U.S. Government has a well-developed set of interoperable identity management standards that meet the NHIN’s privacy, security and confidentiality requirements. These standards are robust and provide the confidence needed to exchange sensitive health information electronically among trusted parties,” said Mollie Shileds-Uehling, president and CEO, SAFE-BioPharma Association.

The full testimony is available at www.safe-biopharma.org/infocenter/SAFEBioPharmaNHINtestimony-1-7-09.pdf.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Advances and hurdles: The impact of AI on oncology care efficiency and mortality rates